Related Experiment Video

Updated: Jun 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Methadone toxicity in infants: a report of two fatalities

V Mistry1, A J Jeffery, W Madira

  • 1Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Forensic Science, Medicine, and Pathology
|January 21, 2010
PubMed

Insights

Methadone toxicity fatalities in infants are rare in the UK. This report details two infant deaths from methadone toxicity, one involving diazepam, highlighting challenges in pediatric forensic toxicology.

Area of Science:

  • Forensic Toxicology
  • Pediatric Toxicology
  • Clinical Toxicology

Background:

  • Methadone toxicity is a significant concern in pediatric populations.
  • Fatalities due to methadone in infants are exceptionally rare in the United Kingdom.
  • Understanding the toxicological profiles of substances in children is crucial for accurate diagnosis and legal proceedings.

Observation:

  • Two cases of infant fatalities attributed to methadone toxicity are presented.
  • The infants were aged 3.5 and 15 months.
  • One fatality also involved co-ingestion of diazepam.

Findings:

  • The study highlights the difficulties in interpreting pediatric forensic toxicology results.
  • Review of current literature on methadone and diazepam toxicity in infants and children is provided.
  • Confirms the rarity of such fatalities while underscoring the potential severity.

Implications:

  • This case series emphasizes the need for careful monitoring and safe storage of methadone and related substances in households with children.
  • It informs pediatricians, toxicologists, and forensic investigators about the potential risks and diagnostic challenges.
  • Contributes to the understanding of drug toxicity in vulnerable pediatric populations.

More Related Videos

Intravenous Injections in Neonatal Mice05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Intravascular Delivery of Biologics to the Rat Kidney07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...